medicare glp 1 coverage obesity CMS Issues Guidance on GLP-1 Anti-Obesity Drugs 🚨 BIG NEWS FOR MEDICARE

Behavior Change Group Better Maintains Weight Loss 11 11 6 out of 7 people stop taking GLP-1s 12

Wear PPE including gloves, lab coat, and protective eyewear Handle compounds within approved laboratory workspaces Avoid inhalation, ingestion, or direct contact Dispose of materials according to institutional chemical waste procedures Maintain proper labeling and documentation for stored research compounds These practices support safe laboratory operation and regulatory compliance

Scientific Research (1) Jozefczak M, Remans T, Vangronsveld J, Cuypers A

14% in placebo-treated individuals

If nausea is severe or persistent, contact your provider about adjusting the dose or escalation schedule